-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
-
Summary
-
Revelation Biosciences, Inc. quarterly/annual Depreciation history and growth rate from Q1 2021 to Q2 2024.
- Revelation Biosciences, Inc. Depreciation for the quarter ending June 30, 2024 was $7.22K, a 15.3% increase year-over-year.
- Revelation Biosciences, Inc. Depreciation for the twelve months ending June 30, 2024 was $26K, a 3.82% increase year-over-year.
- Revelation Biosciences, Inc. annual Depreciation for 2023 was $25K, a 0% increase from 2022.
- Revelation Biosciences, Inc. annual Depreciation for 2022 was $25K, a 49.3% increase from 2021.
Depreciation, Trailing 12 Months (USD)
Depreciation, Quarterly (USD)
Depreciation, YoY Quarterly Growth (%)